CDIP1 antibody (Center)
Quick Overview for CDIP1 antibody (Center) (ABIN499605)
Target
See all CDIP1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Center
-
Specificity
- This antibody reacts to CDIP.
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogen
- CDIP antibody was raised against a 16 amino acid peptide near the center of human CDIP.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
ELISA. Western Blot: CDIP antibody can be used for detection of CDIP at 1 - 2 μg/mL. Immunohistochemistry.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS containing 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C.
-
-
- CDIP1 (LITAF-Like Protein (CDIP1))
-
Alternative Name
- LITAF-Like Protein
-
Background
- The p53 tumor-suppressor gene integrates numerous signals that control cell life and death, loss of its functions contributes to the development of most cancers. CDIP is a novel pro-apoptotic target gene whose inhibition abrogates p53-mediated apoptotic responses. Overexpression of CDIP induced apoptosis in transfected cells while siRNA suppression of caspase-8 mRNA blocked this CDIP-induced apoptosis, indicating that the CDIP-dependent apoptosis pathway proceeds through extrinsic cell death pathway. CDIP may thus represent a novel target for drug design to maximize p53 response and sensitize tumor cells to cancer therapy. Multiple isoforms of CDIP are known to exist.Synonyms: C16orf5, CDIP, Cell death-inducing protein, Transmembrane protein I1
-
Gene ID
- 29965
-
NCBI Accession
- NP_037531
-
UniProt
- Q9H305
Target
-